title: The association between first-episode psychosis and abnormal glycaemic control: systematic review and meta-analysis.
abstract: BACKGROUND
  Schizophrenia might share intrinsic inflammatory disease pathways with type 2 diabetes. We aimed to assess whether first-episode psychosis, which could be described as developing schizophrenia, is associated with prediabetic markers, or developing diabetes, to determine whether intrinsic disease links could cause the disorders to develop in unison. We hypothesised that biochemical measures of prediabetic states would be more common in antipsychotic naive patients with first-episode psychosis than in healthy matched controls.
  
  
  METHODS
  For this systematic review and meta-analysis, using PRISMA criteria, we searched Embase, MEDLINE, PsycINFO, Web of Science, and Google Scholar for clinical studies published between database inception and Jan 6, 2016. We assessed case-control studies with biochemical assessment of prediabetic states in patients with first-episode psychosis alongside matched controls. We sought data at the summary estimate level. Several measurements were used to test for prediabetes, including fasting plasma glucose, insulin resistance (measured by the Homeostatic Model Assessment), and impaired glucose tolerance. We calculated standardised mean differences for each outcome. We used the inverse variance method, for which the weight given to each study was the inverse of the variance of the effect estimate. For dichotomous outcomes, we entered the number of events and number in each group into RevMan 5.3 and used the Mantel-Haenszel method to pool studies.
  
  
  RESULTS
  We identified 1436 studies, of which 12 were included in final analysis, including 1137 participants. Pooled analyses found first-episode psychosis to be related to insulin resistance (mean difference 0·30 [95% CI 0·18 to 0·42]), impaired glucose tolerance (mean difference 1·31 [0·37 to 2·25]), and the number of patients with impaired glucose tolerance (odds ratio 5·44 [2·63 to 11·27]), but not fasting plasma glucose (mean difference 0·03 mmol/L [-0·04 to 0·09]).
  
  
  CONCLUSIONS
  Our findings suggest a potential link between prediabetic markers, in particular impaired glucose tolerance and insulin resistance, and first-episode psychosis. However, we cannot establish causality, and the studies contributing to this review were at some risk of bias. Nevertheless, the findings might help to explain the increased prevalence of type 2 diabetes in patients with schizophrenia and could have implications for the management of patients with schizophrenia.
  
  
  BACKGROUND
  None.
authors.affiliation: Coventry and Warwickshire Partnership NHS Trust, Coventry, UK; Department of Mental Health and Wellbeing, University of Warwick, Coventry, UK. Electronic address: Benjamin.perry@covwarkpt.nhs.uk.
authors.forename: Benjamin Ian
authors.initials: BI
authors.lastname: Perry
authors.affiliation: University Hospitals Birmingham, Birmingham, UK.
authors.forename: Gemma
authors.initials: G
authors.lastname: McIntosh
authors.affiliation: Department of Mental Health and Wellbeing, University of Warwick, Coventry, UK.
authors.forename: Scott
authors.initials: S
authors.lastname: Weich
authors.affiliation: Department of Mental Health and Wellbeing, University of Warwick, Coventry, UK; Birmingham and Solihull Foundation Mental Health Trust, Birmingham, UK.
authors.forename: Swaran
authors.initials: S
authors.lastname: Singh
authors.affiliation: Warwick Medical School, Division of Health Sciences, Statistics and Epidemiology Unit, University of Warwick, Coventry, UK.
authors.forename: Karen
authors.initials: K
authors.lastname: Rees
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology; D018149:Glucose Intolerance / Q000453:epidemiology*; D006801:Humans; D007333:Insulin Resistance; D011618:Psychotic Disorders / Q000097:blood*; D016032:Randomized Controlled Trials as Topic; D012559:Schizophrenia / Q000453:epidemiology